These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15956274)

  • 21. Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature.
    Salahudeen MS; Chyou TY; Nishtala PS
    PLoS One; 2016; 11(3):e0151084. PubMed ID: 26999286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit.
    Plaschke K; Hill H; Engelhardt R; Thomas C; von Haken R; Scholz M; Kopitz J; Bardenheuer HJ; Weisbrod M; Weigand MA
    Anaesthesia; 2007 Dec; 62(12):1217-23. PubMed ID: 17991256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Noben (idebenone) in the treatment of dementia and memory impairment without dementia].
    Voronkova KV; Meleshkov MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):27-32. PubMed ID: 18454094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
    Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
    Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity.
    Carnahan RM; Lund BC; Perry PJ; Pollock BG; Culp KR
    J Clin Pharmacol; 2006 Dec; 46(12):1481-6. PubMed ID: 17101747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic activity and cognitive decline in Parkinson's disease.
    Starkstein SE
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):129. PubMed ID: 20145024
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease.
    Hachisu M; Konishi K; Hosoi M; Tani M; Tomioka H; Kitajima Y; Inamoto A; Hirata A; Koganemaru T; Tomita A; Akashi N; Hori K
    Neurodegener Dis; 2015; 15(3):134-9. PubMed ID: 26138490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.
    Nebes RD; Pollock BG; Halligan EM; Houck P; Saxton JA
    Am J Geriatr Psychiatry; 2011 Feb; 19(2):169-75. PubMed ID: 20808111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of anticholinergic drugs on cognitive impairment in the elderly].
    López-Álvarez J; Zea Sevilla MA; Agüera Ortiz L; Fernández Blázquez MÁ; Valentí Soler M; Martínez-Martín P
    Rev Psiquiatr Salud Ment; 2015; 8(1):35-43. PubMed ID: 25087132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concise cognitive test for dementia screening: reliability and effects of demographic variables as compared to the mini mental state examination.
    Srinivasan S
    Neurol India; 2010; 58(5):702-7. PubMed ID: 21045491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of the Severe Impairment Battery Short Version.
    de Jonghe JF; Wetzels RB; Mulders A; Zuidema SU; Koopmans RT
    J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):954-9. PubMed ID: 19465416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot project to assess the association of anticholinergic symptoms with anticholinergic serum levels in the elderly.
    Remillard AJ
    Pharmacotherapy; 1994; 14(4):482-7. PubMed ID: 7937286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of pharmacological toxicity using serum anticholinergic activity in a patient with dementia.
    Hori K; Funaba Y; Konishi K; Moriyasu M; Hirata K; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):508-10. PubMed ID: 16048459
    [No Abstract]   [Full Text] [Related]  

  • 35. [The adverse effects of anticholinergic drugs].
    Iwaki H; Nomoto M
    Brain Nerve; 2014 May; 66(5):551-60. PubMed ID: 24807371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice.
    Carnahan RM; Lund BC; Perry PJ; Pollock BG
    Psychopharmacol Bull; 2002; 36(2):24-39. PubMed ID: 12397838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum anticholinergic activity: relationship with clinical symptoms in Alzheimer's disease and proposal of new biological marker].
    Hori K; Konishi K; Hachisu M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):135-40. PubMed ID: 21800705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cognitive dysfunction in patients with Parkinson's disease].
    Zakharov VV; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.
    Ancelin ML; Artero S; Portet F; Dupuy AM; Touchon J; Ritchie K
    BMJ; 2006 Feb; 332(7539):455-9. PubMed ID: 16452102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.